Levi & Korsinsky Reminds Beta Bionics, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 3, 2026 - BBNX
Important information regarding Section 20(a) individual liability claims: the lawsuit alleges Beta Bionics' CEO and CFO certified SEC filings while a June 2025 FDA Form 483 citing more than 18,000 unreported iLet complaints was allegedly withheld from shareholders. NEW YORK, Oct. 14,...
Covered in this story
Call it yourself
No calls on $BBNX yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Beta Bionics Inc →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.